Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis
Top Cited Papers
Open Access
- 11 April 2022
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 21 (6) , 1523-1532.e1
Abstract
No abstract availableKeywords
Funding Information
- University of Gothenburg
This publication has 31 references indexed in Scilit:
- Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and MortalityGastroenterology, 2016
- Progression and Natural History of Nonalcoholic Fatty Liver Disease in AdultsClinics in Liver Disease, 2016
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis WorseningGastroenterology, 2016
- UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old AgePLOS Medicine, 2015
- Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver diseaseHepatology, 2014
- Endpoints and clinical trial design for nonalcoholic steatohepatitisHepatology, 2011
- Surrogate markers of insulin resistance: A reviewWorld Journal of Diabetes, 2010
- Non-invasive evaluation of liver fibrosis using transient elastographyJournal of Hepatology, 2008
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005